2025
- Novel needle for intravitreal injections does not affect biological activity of anti-VEGF drugs
Lytvynchuk L, Nolte KL, Fuezy I, Zhou W, Deissler H, Deissler HL.
Clin Ophthalmol. 2025 Nov 17;19:4233-4243. doi: 10.2147/OPTH.S557508. eCollection 2025.PMID: 41282458
-
Influence of PARP1 on CRISPR\/Cas9 induced Double Strand Break repair in proliferating Cells
Wimmer T, Schneider J, Alabudeeb F, Türk FM, Lytvynchuk L, Stieger K.
Comput Struct Biotechnol J. 2025 Oct 2;27:4282-4289. doi: 10.1016/j.csbj.2025.10.001. eCollection 2025.PMID: 41127819
-
Evaluation of CRISPR-Cas9 mismatch activity using a BRET-based reporter system
Wimmer T, Lorenz A, Hoßfeld L, Ponnam G, Prakash S, Lytvynchuk L, Stieger K
Field crops research. - Amsterdam : Elsevier, 1978-. - Online-Ressource. - ISSN 1872-6852. - Band 208 (2025), Artikel-ID: 112256 2025
-
Baruah A, Wimmer T, Stieger K, Ponnam SPG.
Exp Eye Res. 2026 Oct;271:111165. doi: 10.1016/j.exer.2026.111165. Epub 2026 Jul 13.PMID: 42442654
-
Lanzendörfer N, Naranjo Freixa C, Hoffmann I, Stieger K, Deeg CA.
Vet Ophthalmol. 2026 Jul;29(4):e70224. doi: 10.1111/vop.70224.PMID: 42403107
-
Faricimab Reverts VEGF-A165-Induced Impairment of the Barrier Formed by Retinal Endothelial Cells.
Jung DM, Fuezy I, Lytvynchuk L, Deissler HL.
Int J Mol Sci. 2025 May 1;26(9):4318. doi: 10.3390/ijms26094318.PMID: 40362554 -
A model for de novo pigmentation of amelanotic retinal pigment epithelial cells.
Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Faura G, Eide L, Znaor L, Erceg S, Stieger K, Motlik J, Petrovski G.
Acta Ophthalmol. 2026 Mar;104(2):212-224. doi: 10.1111/aos.17572. Epub 2025 Sep 2.PMID: 40892030 -
Lytvynchuk L, Ponomarov M, Reyna EC, Stieger K, Andrassi-Darida M
Clin Ophthalmol. 2025 Mar 12:19:847-856.doi: 10.2147/OPTH.S474942. eCollection 2025.